Navigation Links
25,000 Needless Deaths Each Year Due to Failure to Tackle Blood Clots in Hospital

Up to 25,000 people may die needlessly each year due to the failure to prevent blood clots known as venous thromboembolisms (VTE) in UK hospitals , say experts in this weeks BMJ.

Their warning follows the publication of official guidelines on the issue last month by the National Institute for Health and Clinical Excellence (NICE), which are also summarised in this weeks journal.

It is estimated that VTE kills around 60,000 people every year in the UK and the condition accounts for 10% of all hospital deaths, write David Fitzmaurice and Ellen Murphy from the University of Birmingham. This is 10 times greater than deaths due to MRSA and five times more deaths than breast cancer, AIDS and road traffic accidents combined.

People who have recently had surgery are particularly at risk.

Trials show that drugs can reduce the rate of VTE by up to 65%, yet a Health Select Committee report in 2005 found that only one in five patients at risk were getting them.

The committee instructed NICE to produce guidelines and called for an expert working group to develop a strategy and report back to the chief medical officer.

The expert groups report and the chief medical officers response were published last month, recommending that every adult should have a mandatory VTE risk assessment on admission to hospital and that core standards be set to ensure full compliance with these assessments.

But despite the huge evidence base for preventative treatment, it remains poorly implemented in the UK, say the authors.

A combination of factors may be responsible, they say. For example, health professionals lack awareness due to poor education and venous thromboembolism often occurs after discharge from hospital. Prescribing costs may also be a barrier.

The Health Select Committees report two years ago provided an opportunity to change practice, say the authors. Meanwhil
'"/>




Page: 1 2

Related medicine news :

1. RNIB Receives £25,000 to Help Blin
2. Lack of Timely Intervention Results in Needless Death Due to Stroke in US
3. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
4. Painkiller Linked to Deaths
5. Preventing Childhood Deaths
6. Blood Sugar Linked to Deaths in ICU
7. An Increase In Number Of Lung Cancer Deaths in Women
8. Estimates For Number Of HIV/AIDS Deaths In India Still Not Available
9. Lung Cancer Deaths Declining In Men But Not Women In European Countries
10. Preventable Home Injuries: A Principal Cause Of Deaths In Children
11. Encephalitis Deaths Cross 220 in Uttar Pradesh

Post Your Comments:
(Date:12/4/2009)... North American Seminars Inc....host continuing medical education courses at their...acility to showcase its operation and capabilities...overall costs to educate their physical therapy an...45 facilities hosted over 250 live training events...
(Date:12/4/2009)... , OAKLAND, Calif., Dec. 4 H... among children who have been vaccinated against c... in the December issue of the Pediatric Infectiou...of its kind, used electronic health records to ide...he varicella (chicken pox) vaccine from 2002 to 20...
(Date:12/3/2009)... , SOUTHBRIDGE, Mass., Dec. 3 ...roval to treat its first patients, Harrington Hosp...eing patients immediately," said Diane Becquart, D...The approval was granted today by the Massachusett...nd quality review of the facility. ,, The open...
(Date:12/3/2009)... , CHICAGO, Dec. 3 /PRNewswire-USNewswire/ -... today that the United States District Court for t...minary approval of the previously disclosed $350 m...n lawsuit against UnitedHealth Group. ,, The ac...ate of New York and Missouri State Medical Associa...
(Date:12/3/2009)...ormin outperforms widely used sulfonylureas, but e... , THURSDAY, Dec. 3 (HealthDay News) -- A cla... type 2 diabetes is associated with a higher risk ...t metformin, researchers say. , , Sulfonylureas... less well than metformin in a study of oral anti-...
Breaking Medicine News(10 mins):Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Cancer Center at Harrington to Begin Seeing Patients 2Health News:Cancer Center at Harrington to Begin Seeing Patients 3Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2Health News:Diabetes Drugs Go Head-to-Head in Study 2Health News:Diabetes Drugs Go Head-to-Head in Study 3
...ic bingo to fulfill the unmet needs of ...SACRAMENTO, Calif., May 13 The California Charity...dvocate for the use of,traditional and technologic...e include Disabled Sports USA Far West,Capitol Fre...
...omprehensive Wellness Products and ...3 Veria -- a growing natural,health and wellness ...etwork), local wellness centers, and a lifestyle-f...apeutic massage,services, with 420 clinics open na...
...dward G.,Rendell today signed three bills into law... drug repository program,that allows pharmacies, u...y, to redispense unused cancer drugs to cancer pat...e,drug expires no sooner than six months after the...
...enue increase 12.0 percent demonstrating ...ting for first time since separation; strategic in...ts, - Management updates financial guidance based ...g for the first time since the spin-off of the,fun...
...NDS INC.,(Amex: TOF ) today announced its results...., Net sales for the thirteen weeks ended March 2...h net sales of $4.85 million for the thirteen,week...iod., For the thirteen weeks ended March 29, 2008...
...ts.com,Inc. (Nasdaq: DIET ), leveraging the power... lifestyle solutions to everyone, today announced,...venues for the first quarter of 2008 were $8.8 mil...irst quarter of,2008, compared to $(1.3) million, ...
Other Medicine News:Health News:Charities Form Alliance to Preserve and Improve Charity Bingo 2Health News:Veria Announces Acquisition of Massage Envy Ltd. 2Health News:Veria Announces Acquisition of Massage Envy Ltd. 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 2Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 4Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 5Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 6Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 7Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 8Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 9Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 10Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 11Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 12Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 13Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 14Health News:TOFUTTI Announces First Quarter Results 2Health News:TOFUTTI Announces First Quarter Results 3Health News:TOFUTTI Announces First Quarter Results 4Health News:eDiets.com(R) Announces Q1 2008 Results 2Health News:eDiets.com(R) Announces Q1 2008 Results 3Health News:eDiets.com(R) Announces Q1 2008 Results 4Health News:eDiets.com(R) Announces Q1 2008 Results 5Health News:eDiets.com(R) Announces Q1 2008 Results 6
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Ted Karkus, Chairman and ...www.quigleyco.com announced today that the Compan...s to develop prescription pharmaceutical and OTC p...nterests to focus primarily on the OTC/Personal Ca...ted to its Cold-EEZE® and Kids-EEZE® bra...
(Date:12/3/2009)...3 Wound Management T...pidly growing provider of specialty medical produc...ndustry Representative Association (HIRA) to serve...g representative to market the company,s core Cell...A will market and sell Wound Management Technologi...
(Date:12/3/2009)...ire/ -- Apnex Medical, Inc., a private medical dev...ond round of private equity financing totaling $14...nical study and develop a second generation of its...eat obstructive sleep apnea (OSA). ,, Participa...w Enterprise Associates (NEA), Polaris Venture Par...
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3Jellyfish Protein Extends Neuroprotective Tentacles at Neuroscience Conference 14588 1Jellyfish Protein Extends Neuroprotective Tentacles at Neuroscience Conference 14588 2Jellyfish Protein Extends Neuroprotective Tentacles at Neuroscience Conference 14588 3Mimotopes Launches Online Peptide Superstore 14585 1Mimotopes Launches Online Peptide Superstore 14585 2Mimotopes Launches Online Peptide Superstore 14585 3Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action October 24 2009 14582 1Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action October 24 2009 14582 2Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action October 24 2009 14582 3
...lment in May 2009; Reinforces Lilly,s commitment t... , , INDIANAPOLIS, May 21 Eli Lilly and Company...lling patients this month in two separate but iden... previously referred to as LY2062430, an anti-amyl... a potential treatment to delay the progression of...
...Application (NDA) to the U.S. Food and Drug Admini...nippon Sumitomo Pharma Co., Ltd., (DSP) announced ...ical trial for lurasidone, which is under clinical...ts with schizophrenia. In this six-week, double-b...ay was significantly more effective than placebo f...
Other Medicine Technology:Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 2Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 3Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 4Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 5Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia 2Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia 3Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia 4Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia 5
Seattle Small Joint Arthroscopy Cup Currette
...he Small Fragment Plate and Screw System provides ... on angular deformities; particularly the opening ... hallux valgus correction). The Small Fragment Pla... with a removable caddy that houses the plates, sc...
Teardrop punch, Right
LactoSorb® No-Profile Screw and Washer
Medicine Products: